专题:Retinal and Optic Conditions

This cluster of papers explores the ocular manifestations of COVID-19, including its impact on the eyes, such as retinal artery occlusion, conjunctivitis, viral shedding in tears and secretions, and the expression of ACE2 receptor on the ocular surface. It also delves into specific conditions like Susac syndrome and utilizes techniques like optical coherence tomography to study these manifestations.
最新文献
Ground Truth Reliability and Clinical Generalisability in Deep Learning for Reticular Pseudodrusen

article Full Text OpenAlex

Closing the Transparency Gap in Ophthalmology Society Conflicts of Interest

article Full Text OpenAlex

Optimized Deep Learning Framework for Diabetic Retinopathy Detection and Classification Using Fundus Imaging

article Full Text OpenAlex

Prevalence and associations of central serous chorioretinopathy in a population aged 50+ years. The Beijing Eye Study

article Full Text OpenAlex

Herpes zoster after COVID-19 as a marker of long-term neuro-ophthalmic risk

article Full Text OpenAlex

Acute Unilateral Vision Loss Following Recombinant Zoster (Shingrix) Vaccination: A Case of Presumptive Purtscher-Like Retinopathy

article Full Text OpenAlex

Choroid plexus alterations in long COVID and their associations with Alzheimer's disease risks

article Full Text OpenAlex

A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion

article Full Text OpenAlex

Intraocular Inflammation After Intravitreal Faricimab Injections: A Case Series

article Full Text OpenAlex

Intraocular inflammation incidence and real-world safety of intravitreal faricimab treatment across retinal indications

article Full Text OpenAlex

近5年高被引文献
A foundation model for generalizable disease detection from retinal images

article Full Text OpenAlex 730 FWCI168.8995

Risks and burdens of incident diabetes in long COVID: a cohort study

article Full Text OpenAlex 489 FWCI60.314

Optical Coherence Tomography of Ocular Diseases

book Full Text OpenAlex 482 FWCI19.68

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

article Full Text OpenAlex 398 FWCI76.1767

Age-related macular degeneration

review Full Text OpenAlex 395 FWCI116.5946

Infusion Therapy Standards of Practice, 9th Edition

article Full Text OpenAlex 387 FWCI144.8319

Age-Related Macular Degeneration

review Full Text OpenAlex 377 FWCI218.5581

Prevalence of Age-Related Macular Degeneration in the US in 2019

article Full Text OpenAlex 232 FWCI43.9029

Deep Learning Techniques for Diabetic Retinopathy Classification: A Survey

article Full Text OpenAlex 232 FWCI31.9843

Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications

review Full Text OpenAlex 229 FWCI41.0441